NFA
LUMO

Nationwide Fund Advisors’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Nationwide Fund Advisors’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,426
Closed -$131K – 2238
2017
Q3 		$131K Hold
1,426
– – ﹤0.01% 2801
2017
Q2 		$94K Hold
1,426
– – ﹤0.01% 2928
2017
Q1 		$309K Sell
1,426
-147
-9% -$21K ﹤0.01% 2402
2016
Q4 		$146K Hold
1,573
– – ﹤0.01% 2747
2016
Q3 		$213K Hold
1,573
– – ﹤0.01% 2592
2016
Q2 		$159K Buy
1,573
+85
+6% +$10.5K ﹤0.01% 2717
2016
Q1 		$244K Sell
1,488
-38
-2% -$7.7K ﹤0.01% 2439
2015
Q4 		$500K Buy
1,526
+37
+2% +$12K ﹤0.01% 2118
2015
Q3 		$480K Hold
1,489
– – ﹤0.01% 2142
2015
Q2 		$593K Sell
1,489
-123
-8% -$52.3K ﹤0.01% 2150
2015
Q1 		$794K Sell
1,612
-62
-4% -$24K ﹤0.01% 2005
2014
Q4 		$599K Sell
1,674
-27
-2% -$8.04K ﹤0.01% 2077
2014
Q3 		$328K Buy
1,701
+12
+0.7% +$2.64K ﹤0.01% 2463
2014
Q2 		$403K Buy
1,689
+195
+13% +$39.7K ﹤0.01% 2377
2014
Q1 		$382K Sell
1,494
-620
-29% -$190K ﹤0.01% 2187
2013
Q4 		$419K Sell
2,114
-38
-2% -$6.76K ﹤0.01% 2323
2013
Q3 		$364K Buy
2,152
+798
+59% +$128K ﹤0.01% 2376
2013
Q2 		$240K Buy
+1,354
New +$192K ﹤0.01% 2399

Other funds holding LUMO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nationwide Fund Advisors's LUMO Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q4 2017, closing a stake of 1,426 shares — an estimated $131K sold.

Nationwide Fund Advisors first reported a position in LUMO in Q2 2013 and held it in 18 quarters. The position peaked at $794K in Q1 2015. 130 funds tracked by Wall St. Rank hold LUMO as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Lumos Pharma, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 1,426 Lumos Pharma, Inc. Common Stock shares in Q4 2017, an estimated $131K.
  • Nationwide Fund Advisors first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's Lumos Pharma, Inc. Common Stock position peaked at $794K in Q1 2015.
  • 130 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.